Contribute Try STAT+ Today

14oct1:00 pmCAR-T comes of age?Virtual Hosted by: STAT

Hosted by


Event Details

It’s been almost a decade since the release of the first stunning data on a cell therapy that battled blood cancer by genetically altering a patient’s own white blood cells to attack it.

Many years and billions of dollars in mergers and acquisitions later, CAR-T is still used mostly as a last resort. Could new clinical trials that are about to report out in full change that?

STAT’s Adam Feuerstein gathers experts to look ahead.


Oct. 14, 1-2 p.m.